Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus ketorolac for acute pain control in chest trauma with rib fractures or chest tube insertion
IRCT20210711051840N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketamine, ketorolac, acetaminophen and morphine in acute pain (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Pain relief with ketamine at 60 minutes. Started Apr 2023; status: completed.
02
Drugs
ketamineketorolacacetaminophenmorphine
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20210711051840N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210711051840N1.